Scalable Efficient Expansion of Mesenchymal Stem Cells in Xeno Free Media Using Commercially Available Reagents XcytePLUSâ„¢ media, a human platelet lysate based product, was used to supplement culture medium at 5, 7.5 and 10% and compared to fetal calf serum (FCS) at 10%, for human umbilical cord mesenchymal stem cell expansion. They demonstrated equivalent or superior effects of human platelet lysate compared to standard FCS supplemented media, based on doubling rate, without loss of identity or function, as demonstrated with flow cytometry characterization. [J Transl Med] Full Article Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua Researchers present a first safety follow-up on their clinical experience with placenta-derived decidual stromal cells, used as supportive immunomodulatory and regenerative therapy for patients with severe complications after allogeneic hematopoietic stem cell transplantation. [Stem Cells Dev] Abstract Metabolic Syndrome in Adults Who Received Hematopoietic Stem Cell Transplantation for Acute Childhood Leukemia: An LEA Study Researchers evaluated prospectively the incidence and risk factors of the metabolic syndrome and its components in 170 adult patients who received an hematopoietic stem cell transplantation for childhood. [Bone Marrow Transplant] Abstract Wharton’s Jelly-Derived Mesenchymal Stem Cells Alleviate Memory Deficits and Reduce Amyloid-β Deposition in an APP/PS1 Transgenic Mouse Model Investigators evaluated the therapeutic effect of Wharton’s Jelly-derived mesenchymal stem cells transplantation on the neuropathology and memory deficits in amyloid precursor protein and presenilin-1 double-transgenic mice. [Clin Exp Med] Abstract Dehydrated Human Amnion/Chorion Membrane Regulates Stem Cell Activity In Vitro PURION® Processed dehydrated human amnion/chorion membrane allografts were evaluated for their ability to alter stem cell activity in vitro. [J Biomed Mater Res B Appl Biomater] Abstract | Press Release Comparative Analysis of Human Mesenchymal Stem Cells from Fetal-Bone Marrow, Adipose Tissue, and Warton’s Jelly as Sources of Cell Immunomodulatory Therapy Scientists compared human fetal bone marrow, adipose tissue, and Warton’s jelly-derived MSCs (WJ-MSCs) for surface antigen expression, differentiation ability, proliferation capacity, clonality, tolerance for aging, gene expression, and whether IFN-γ affected WJ-MSC gene expression, as determined by real time quantitative PCR. [Hum Vaccin Immunother] Abstract Effect of Targeted Ovarian Cancer Therapy Using Amniotic Fluid Mesenchymal Stem Cells Transfected with Enhanced Green Fluorescent Protein-Human Interleukin-2 in Vivo Investigators found that amniotic fluid mesenchymal stem cells (AF-MSCs) exhibited high motility during migration in vivo and the vector, pEGFP‑hIL‑2, can be stably transfected into AF‑MSCs. Following stable transfection, this type of stem cell was able to successfully transport the therapeutic gene, IL-2, migrate to the ovarian cancer tumor site to secrete the functional IL-2 and treat the tumor. [Mol Med Rep] Abstract |